1h Free Analyst Time
The Luciferase Assays Market size was estimated at USD 1.40 billion in 2022, USD 1.50 billion in 2023, growing at a CAGR of 7.01% to reach USD 2.42 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Luciferase Assays Market.- Based on Method, the market is studied across Dual Reporter Assay, Flash Assay, Glow Assay, and Single Reporter Assay. The Flash Assay is projected to witness significant market share during forecast period.
- Based on Application, the market is studied across Gеnе Eхрrеѕѕіоn, Меtаbоlіс Aсtіvіtу, Рrоtеіn-Prоtеіn Intеrасtіоn, and Роѕt-Trаnѕlаtіоnаl Mоdіfісаtіоn. The Роѕt-Trаnѕlаtіоnаl Mоdіfісаtіоn is projected to witness significant market share during forecast period.
- Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Europe, Middle East & Africa is projected to witness significant market share during forecast period.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Luciferase Assays Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Luciferase Assays Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.Key Company Profiles:
The report delves into recent significant developments in the Luciferase Assays Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Active Motif, Inc., Biotium, GeneCopoeia, Inc., Gold Biotechnology, Invivogen, Lonza Group AG, Merck KGaA, Molecular Devices, LLC, Novus Biologicals, OriGene Technologies, Inc., OZ Biosciences, Perkin Elmer, Inc., Promega Corporation, PromoCell GmbH, SwitchGear Genomics, Inc., Takara Bio Inc., and Thermo Fisher Scientific, Inc.The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast for the Luciferase Assays Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Luciferase Assays Market?
- What is the competitive strategic window for identifying opportunities in the Luciferase Assays Market?
- What are the latest technology trends and regulatory frameworks in the Luciferase Assays Market?
- What is the market share of the leading vendors in the Luciferase Assays Market?
- Which modes and strategic moves are suitable for entering the Luciferase Assays Market?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Luciferase Assays Market, by Method
7. Luciferase Assays Market, by Application
8. Americas Luciferase Assays Market
9. Asia-Pacific Luciferase Assays Market
10. Europe, Middle East & Africa Luciferase Assays Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix
List of Figures
List of Tables
Companies Mentioned
- AAT Bioquest, Inc.
- Abcam PLC
- Active Motif, Inc.
- Biotium
- GeneCopoeia, Inc.
- Gold Biotechnology
- Invivogen
- Lonza Group AG
- Merck KGaA
- Molecular Devices, LLC
- Novus Biologicals
- OriGene Technologies, Inc.
- OZ Biosciences
- Perkin Elmer, Inc.
- Promega Corporation
- PromoCell GmbH
- SwitchGear Genomics, Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.5 Billion |
| Forecasted Market Value ( USD | $ 2.42 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
